Analyst's thumbs up for UK's NMT:
This article was originally published in Clinica
After a site visit to the UK needleless injector company, NMT Group, at which a second generation safety syringe was unveiled, analysts at WestLB Panmure Gordon came away praising the company's "world-beating future product". The analysts concluded that the device was probably further developed than Becton Dickinson - the "only other company with an advanced second generation product in development", they said. NMT nearly ceased trading this time last year as delays and poor take up meant it ran out of cash.